Viral Optimism: The Pfizer-BioNTech Vaccine – OpEd

The announcement that Pfizer Inc., along with its collaborative partner BioNTech SE, had come up with a successful vaccine candidate to combat the novel coronavirus SARS-CoV-2 sent the markets soaring.  In New York, Pfizer’s shares rose by 15 percent in pre-market trading; those of BioNTech, Nasdaq-listed, rose 25 percent. ...